Neural Activities Are Unfavorable for the Prognosis of Ovarian Cancer Through Mrna Expression Analysis

References

• Torre LA , TrabertB, DeSantisCEet al. Ovarian cancer statistics, 2018. CA Cancer J. Clin.68 (4), 284–296 (2018).
   PubMed Web of Science ®Google Scholar
• Carter JS , DownsLS. Ovarian cancer tests and treatment. Female Patient (Parsippany).36 (4), 30–35 (2011).
   Google Scholar
• Das PM , BastRC. Early detection of ovarian cancer. Biomark. Med.2 (3), 291–303 (2008).
   PubMed Web of Science ®Google Scholar
• Rustin G , van der BurgM, GriffinC, QianW, SwartAM. Early versus delayed treatment of relapsed ovarian cancer. Lancet377 (9763), 380–381 (2011).
   PubMed Web of Science ®Google Scholar
• Weis SM , ChereshDA. Tumor angiogenesis: molecular pathways and therapeutic targets. Nat Med.17 (11), 1359–1370 (2011).
   PubMed Web of Science ®Google Scholar
• Wurmser AE , NakashimaK, SummersRGet al. Cell fusion-independent differentiation of neural stem cells to the endothelial lineage. Nature430 (6997), 350–356 (2004).
   PubMed Web of Science ®Google Scholar
• Bussolati B , GrangeC, BrunoSet al. Neural-cell adhesion molecule (NCAM) expression by immature and tumor-derived endothelial cells favors cell organization into capillary-like structures. Exp. Cell Res.312 (6), 913–924 (2006).
   PubMed Web of Science ®Google Scholar
• Varner JA . Stem cells, angiogenesis, and neurogenesi s in tumors. In : Stem Cells and Cancer. Humana Press, CA, USA, 247–252 (2009). https://link.springer.com/chapter/10.1007/978-1-60327-933-8_19.
   Google Scholar
• Network TCGAR . Integrated genomic analyses of ovarian carcinoma. Nature474 (7353), 609–615 (2011).
   PubMed Web of Science ®Google Scholar
• Anaya J . OncoLnc: linking TCGA survival data to mRNAs, miRNAs, and lncRNAs. PeerJ Comput. Sci.2, e67 (2016).
   Web of Science ®Google Scholar
• Ashburner M , BallCA, BlakeJAet al. Gene Ontology: tool for the unification of biology. Nat. Genet.25 (1), 25–29 (2000).
   PubMed Web of Science ®Google Scholar
• Anaya J , ReonB, ChenW-M, BekiranovS, DuttaA. A pan-cancer analysis of prognostic genes. PeerJ.3, e1499 (2016).
   PubMedGoogle Scholar
• Tang Z , LiC, KangB, GaoG, LiC, ZhangZ. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res.45 (Web Server issue), W98–W102 (2017).
   PubMedGoogle Scholar
• Szklarczyk D , FranceschiniA, WyderSet al. STRING v10: protein–protein interaction networks, integrated over the tree of life. Nucleic Acids Res.43 (Database issue), D447–D452 (2015).
   PubMed Web of Science ®Google Scholar
• Carmeliet P , JainRK. Angiogenesis in cancer and other diseases. Nature407 (6801), 249–257 (2000).
   PubMed Web of Science ®Google Scholar
• Warde-Farley D , DonaldsonSL, ComesOet al. The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res.38 (Web Server issue), W214–W220 (2010).
   PubMed Web of Science ®Google Scholar
• Jobling P , PundavelaJ, OliveiraSMR, RoselliS, WalkerMM, HondermarckH. Nerve–cancer cell cross-talk: a novel promoter of tumor progression. Cancer Res.75 (9), 1777–1781 (2015).
   PubMed Web of Science ®Google Scholar
• Ayala GE , WheelerTM, ShineHDet al. In vitro dorsal root ganglia and human prostate cell line interaction: redefining perineural invasion in prostate cancer. Prostate49 (3), 213–223 (2001).
   PubMed Web of Science ®Google Scholar
• Hanoun M , MaryanovichM, Arnal-EstapéA, FrenettePS. Neural regulation of hematopoiesis, inflammation, and cancer. Neuron86 (2), 360–373 (2015).
   PubMed Web of Science ®Google Scholar
• Magnon C , HallSJ, LinJet al. Autonomic nerve development contributes to prostate cancer progression. Science341 (6142), 1236361 (2013).
   PubMed Web of Science ®Google Scholar
• Lu R , FanC, ShangguanWet al. Neurons generated from carcinoma stem cells support cancer progression. Signal Transduct. Target. Ther.2, 16036 (2017).
   PubMed Web of Science ®Google Scholar
• Albo D , AkayCL, MarshallCLet al. Neurogenesis in colorectal cancer is a marker of aggressive tumor behavior and poor outcomes. Cancer117 (21), 4834–4845 (2011).
   PubMed Web of Science ®Google Scholar
• Zhao C-M , HayakawaY, KodamaYet al. Denervation suppresses gastric tumorigenesis. Sci Transl Med.6 (250), 250ra115 (2014).
   PubMed Web of Science ®Google Scholar
• Fabregat A , JupeS, MatthewsLet al. The Reactome Pathway Knowledgebase. Nucleic Acids Res.46 (Database issue), D649–D655 (2018).
   PubMedGoogle Scholar
• Russell SA , BashawGJ. Axon guidance pathways and the control of gene expression. Developmental Dynamics247 (4), 571–580 (2017).
   Web of Science ®Google Scholar
• Arese M , BussolinoF, PergolizziM, BizzozeroL, PascalD. Tumor progression: the neuronal input. Ann Transl Med.6 (5), (2018).
   PubMed Web of Science ®Google Scholar
• Kennedy TE , SerafiniT, de la TorreJ, Tessier-LavigneM. Netrins are diffusible chemotropic factors for commissural axons in the embryonic spinal cord. Cell78 (3), 425–435 (1994).
   PubMed Web of Science ®Google Scholar
• Püschel AW . Semaphorins: repulsive guidance molecules show their attractive side. Nat. Neurosci.2 (9), 777–778 (1999).
   PubMed Web of Science ®Google Scholar
• Serafini T , KennedyTE, GaikoMJ, MirzayanC, JessellTM, Tessier-LavigneM. The netrins define a family of axon outgrowth-promoting proteins homologous to C. elegans UNC-6. Cell78 (3), 409–424 (1994).
   PubMed Web of Science ®Google Scholar
• Ylivinkka I , Keski-OjaJ, HyytiäinenM. Netrin-1: a regulator of cancer cell motility?Eur. J. Cell Biol.95 (11), 513–520 (2016).
   PubMed Web of Science ®Google Scholar
• Serafini T , ColamarinoSA, LeonardoEDet al. Netrin-1 is required for commissural axon guidance in the developing vertebrate nervous system. Cell87 (6), 1001–1014 (1996).
   PubMed Web of Science ®Google Scholar
• Wang L , ZhiX, ZhuYet al. MUC4-promoted neural invasion is mediated by the axon guidance factor netrin-1 in PDAC. Oncotarget6 (32), 33805–33822 (2015).
   PubMedGoogle Scholar
• Fitamant J , GuenebeaudC, CoissieuxM-Met al. Netrin-1 expression confers a selective advantage for tumor cell survival in metastatic breast cancer. PNAS105 (12), 4850–4855 (2008).
   PubMed Web of Science ®Google Scholar
• Antibody targeting of the EphA2 tyrosine kinase inhibits malignant cell behavior. Cancer Res.62 (10), 2840–2847 (2002).
   PubMed Web of Science ®Google Scholar
• Wicks IP , WilkinsonD, SalvarisE, BoydAW. Molecular cloning of HEK, the gene encoding a receptor tyrosine kinase expressed by human lymphoid tumor cell lines. Proc. Natl Acad. Sci. USA89 (5), 1611–1615 (1992).
   PubMed Web of Science ®Google Scholar
• Kiyokawa E , TakaiS, TanakaMet al. Overexpression of ERK, an EPH family receptor protein tyrosine kinase, in various human tumors. Cancer Res.54 (14), 3645–3650 (1994).
   PubMed Web of Science ®Google Scholar
• Easty DJ , HerlynM, BennettDC. Abnormal protein tyrosine kinase gene expression during melanoma progression and metastasis. Int. J. Cancer60 (1), 129–136 (1995).
   PubMed Web of Science ®Google Scholar
• Cheng N , BrantleyDM, ChenJ. The ephrins and Eph receptors in angiogenesis. Cytokine Growth Factor Rev.13 (1), 75–85 (2002).
   PubMed Web of Science ®Google Scholar